Effects of low doses of casein hydrolysate on post-challenge glucose and insulin levels

European Journal of Internal Medicine

Volumn 22, Issue 3, 2011, Pages 245-248

  Jonker, J T ^a   Wijngaarden, M A ^a   Kloek, J ^b   Groeneveld, Y ^a   Gerhardt, C ^b   Brand, R ^a   Kies, A K ^b   Romijn, J A ^a   Smit, J W A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DSM FOOD SPECIALTIES   (Netherlands)

Author keywords

Casein hydrolysate; Diabetes mellitus; Oral glucose tolerance test; Protein hydrolysates

Indexed keywords

C PEPTIDE; CARBOHYDRATE; CASEIN HYDROLYSATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INSULIN SENSITIVITY; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; C-PEPTIDE; CASEINS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 79956037166     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.12.015     Document Type: Article

References (20)

1. Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 2006;91:813-9. (Pubitemid 43357744)
2. Bonora E, Corrao G, Bagnardi V, Ceriello A, Comaschi M, Montanari P, et al. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia 2006;49:846-54.
3. Claessens M, Calame W, Siemensma AD, van Baak MA, Saris WH. The effect of different protein hydrolysate/carbohydrate mixtures on postprandial glucagon and insulin responses in healthy subjects. Eur J Clin Nutr 2007;63(1):48-56.
4. Manders RJ, Wagenmakers AJ, Koopman R, Zorenc AH, Menheere PP, Schaper NC, et al. Co-ingestion of a protein hydrolysate and amino acid mixture with carbohydrate improves plasma glucose disposal in patients with type 2 diabetes. Am J Clin Nutr 2005;82:76-83. (Pubitemid 41716380)
5. Manders RJ, Praet SF, Meex RC, Koopman R, de Roos AL, Wagenmakers AJ, et al. Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients. Diab Care 2006;29:2721-2. (Pubitemid 44912205)
6. Manders RJ, Koopman R, Sluijsmans WE, van den Berg R, Verbeek K, Saris WH, et al. Co-ingestion of a protein hydrolysate with or without additional leucine effectively reduces postprandial blood glucose excursions in Type 2 diabetic men. J Nutr 2006;136:1294-9.
7. van Loon LJ, Kruijshoop M, Menheere PP, Wagenmakers AJ, Saris WH, Keizer HA. Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diab Care 2003;26:625-30. (Pubitemid 36929318)
8. Koopman R, Crombach N, Gijsen AP, Walrand S, Fauquant J, Kies AK, et al. Ingestion of a protein hydrolysate is accompanied by an accelerated in vivo digestion and absorption rate when compared with its intact protein. Am J Clin Nutr 2009;90:106-15.
9. Mahe S, Roos N, Benamouzig R, Davin L, Luengo C, Gagnon L, et al. Gastrojejunal kinetics and the digestion of [15 N]beta-lactoglobulin and casein in humans: the influence of the nature and quantity of the protein. Am J Clin Nutr 1996;63:546-52.
10. Manders RJ, Praet SF, Vikstrom MH, Saris WH, van Loon LJ. Protein hydrolysate co-ingestion does not modulate 24 h glycemic control in long-standing type 2 diabetes patients. Eur J Clin Nutr 2007;63(1):121-6.
11. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diab Care 1999;22:1462-70. (Pubitemid 29418240)
12. Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diab Res Clin Pract 1990;10:167-75. (Pubitemid 20350538)
13. Floyd Jr JC, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest 1966;45:1487-502.
14. Floyd Jr JC, Fajans SS, Pek S, Thiffault CA, Knopf RF, Conn JW. Synergistic effect of certain amino acid pairs upon insulin secretion in man. Diabetes 1970;19:102-8.
15. Rabinowitz D, Merimee TJ, Maffezzoli R, Burgess JA. Patterns of hormonal release after glucose, protein, and glucose plus protein. Lancet 1966;2:454-6.
16. Brennan L, Shine A, Hewage C, Malthouse JP, Brindle KM, McClenaghan N, et al. A nuclear magnetic resonance-based demonstration of substantial oxidative L-alanine metabolism and L-alanine-enhanced glucose metabolism in a clonal pancreatic beta-cell line: metabolism of L-alanine is important to the regulation of insulin secretion. Diabetes 2002;51:1714-21. (Pubitemid 34564282)
17. Newsholme P, Brennan L, Rubi B, Maechler P. New insights into amino acid metabolism, beta-cell function and diabetes. Clin Sci (Lond) 2005;108:185-94. (Pubitemid 40343565)
18. Dunne MJ, Yule DI, Gallacher DV, Petersen OH. Effects of alanine on insulin-secreting cells: patch-clamp and single cell intracellular Ca2+ measurements. Biochim Biophys Acta 1990;1055:157-64. (Pubitemid 20372029)
19. Claessens M, Saris WH, van Baak MA. Glucagon and insulin responses after ingestion of different amounts of intact and hydrolysed proteins. Br J Nutr 2008;100:61-9.
20. Spiller GA, Jensen CD, Pattison TS, Chuck CS, Whittam JH, Scala J. Effect of protein dose on serum glucose and insulin response to sugars. Am J Clin Nutr 1987;46:474-80. (Pubitemid 18003385)